Information Journal Paper
APA:
Copy. (2019). Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, 38(1), 368-368. SID. https://sid.ir/paper/970760/en
Vancouver:
Copy. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH[Internet]. 2019;38(1):368-368. Available from: https://sid.ir/paper/970760/en
IEEE:
Copy, “Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?,” JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, vol. 38, no. 1, pp. 368–368, 2019, [Online]. Available: https://sid.ir/paper/970760/en